As a Keymaker, we know that there isn’t a skeleton key that fits every person. And because of that we work hard to design the support & programing that you, your youth & family needs. That means if ...
Results from sub-study 03A of KEYMAKER-U03, an international, open-label, rolling-arm, phase I/II umbrella trial, spotlight the promise of pembrolizumab-based regimens combined with tyrosine kinase ...
As a Keymaker, we know that there isn’t a skeleton key that fits every person. And because of that we work hard to design the support & programing that you, your youth & family needs. That means if ...
Phase 3 trial of the therapeutic cancer vaccine OSE2101 versus docetaxel in patients with metastatic non-small cell lung cancer and secondary resistance to immunotherapy. This is an ASCO Meeting ...
KEYMAKER-U03 is an international, multicenter, open-label, Phase I/II umbrella trial evaluating experimental combinations of pembrolizumab-based immunotherapy and targeted treatments for advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results